Company / Operating Cash Flow per Share
Centessa Pharmaceuticals plc Operating Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.30
FY2025
5-year range
-$2.15 / -$1.07
FY2021-FY2025
Trend
-21.3%
vs FY2024
Sector context
#130 of 212
Health Care
What the data says
At $-1.30, Centessa Pharmaceuticals plc's operating cash flow per share ranks #130 of 212 in the Health Care sector. Improved from $-1.69 to $-1.30 over the past 2 years.
Based on SEC 10-K filings.
-1.30 in FY2025.
Improved from $-1.69 to $-1.30 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#130 of 212 in Health CareTop 61% of 212This company -$1.30 Sector average -$14.69
▼
+91.2% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 21.3% year-over-year.
- Ranks #130 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.30 | -21.3% |
| FY2024 | -$1.07 | +36.6% |
| FY2023 | -$1.69 | +21.3% |
| FY2022 | -$2.15 | -19.5% |
| FY2021 | -$1.80 | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026